Department of Intensive Care and Department of Medicine, Austin & Repatriation Medical Centre, Melbourne, Australia; Division of Critical Care Medicine, University of Alberta, Edmonton, Canada.
J Crit Care. 2013 Dec;28(6):1011-8. doi: 10.1016/j.jcrc.2013.08.002. Epub 2013 Sep 24.
To evaluate the characteristics and outcomes of critically ill patients with severe acute kidney injury (AKI) treated and not treated with renal replacement therapy (RRT).
Secondary analysis of a multi-centre cohort study. Primary exposure was RRT. Primary outcome was propensity and multi-variable adjusted-hospital mortality.
We studied 1250 patients (71.3%) who received and 502 (28.7%) who did not receive RRT. Reasons for not starting RRT (not mutually exclusive) were limitations of support (33.6%, n = 169), adequate urine output (46.2%; n = 232), plan to observe (56.4%; n = 283), and advanced age (12.6%; n = 63). Mortality was higher in those not receiving RRT due to limitations and advanced age but lower for adequate urine output and plan to observe. Propensity and multi-variable adjusted analysis showed no statistical difference in hospital mortality (adj-OR 1.47; 95% CI, 0.93-2.24) in patients receiving RRT. Results were similar in a sensitivity analysis restricted to patients fulfilling risk, injury, failure, loss, end-stage kidney disease-FAILURE criteria (37.0%; n = 446) (adj-OR 1.36; 95% CI, 0.70-2.66).
In this cohort, reasons for not starting RRT included limitations of support and perception of impending renal recovery. Despite similar risk of mortality after adjusting for selection bias and confounders, RRT-treated patients were fundamentally different from non-treated patients across a spectrum of variables that precludes valid comparison in observational data.
评估接受和未接受肾脏替代治疗(RRT)的重症急性肾损伤(AKI)危重病患者的特征和结局。
多中心队列研究的二次分析。主要暴露因素为 RRT。主要结局为倾向和多变量校正后的住院死亡率。
我们研究了 1250 名接受 RRT 治疗的患者(71.3%)和 502 名未接受 RRT 治疗的患者(28.7%)。未开始 RRT 的原因(非互斥)包括支持限制(33.6%,n=169)、尿量充足(46.2%,n=232)、观察计划(56.4%,n=283)和高龄(12.6%,n=63)。由于支持限制和高龄,未接受 RRT 的患者死亡率更高,但由于尿量充足和观察计划,死亡率较低。倾向和多变量校正分析显示,接受 RRT 的患者住院死亡率无统计学差异(调整后 OR 1.47;95%CI,0.93-2.24)。在仅纳入符合风险、损伤、衰竭、丧失、终末期肾病-FAILURE 标准(37.0%,n=446)的患者的敏感性分析中,结果也相似(调整后 OR 1.36;95%CI,0.70-2.66)。
在本队列中,未开始 RRT 的原因包括支持限制和即将发生肾恢复的感知。尽管在调整选择偏倚和混杂因素后,死亡率的风险相似,但 RRT 治疗的患者与未治疗的患者在一系列变量上存在根本差异,这些差异使得在观察性数据中无法进行有效的比较。